Rachel Rubin’s Bio

Rachel Rubin is an Analyst at Avascent, where she provides corporate clients with research and analysis for defense and next-gen technology systems, as well as federal IT and cyber strategy support. Rachel has also supported Avascent’s M&A Transaction practice, providing private equity clients with due-diligence reports to validate financial viability, forecasted upside, and market positioning of acquisition targets.

Education

Rachel graduated summa cum laude from American University with a BA in International Relations.

rrubin@avascent.com